Hibernation-Based Approaches in the Treatment of Hemorrhagic Shock

Andrea Wolf; Elizabeth R. Lusczek; Gregory J. Beilman

doi:10.1097/SHK.0000000000001094

Hibernation-Based Approaches in the Treatment of Hemorrhagic Shock

Andrea Wolf, Elizabeth R. Lusczek, Gregory J. Beilman

Surgery

Research output: Contribution to journal › Review article › peer-review

11 Scopus citations

Abstract

Hemorrhagic shock is the leading cause of preventable death after trauma. Hibernation-based treatment approaches have been of increasing interest for various biomedical applications. Owing to apparent similarities in tissue perfusion and metabolic activity between severe blood loss and the hibernating state, hibernation-based approaches have also emerged for the treatment of hemorrhagic shock. Research has shown that hibernators are protected from shock-induced injury and inflammation. Utilizing the adaptive mechanisms that prevent injury in these animals may help alleviate the detrimental effects of hemorrhagic shock in non-hibernating species. This review describes hibernation-based preclinical and clinical approaches for the treatment of severe blood loss. Treatments include the delta opioid receptor agonist D-Ala 2-Leu 5-enkephalin (DADLE), the gasotransmitter hydrogen sulfide, combinations of adenosine, lidocaine, and magnesium (ALM) or D-beta-hydroxybutyrate and melatonin (BHB/M), and therapeutic hypothermia. While we focus on hemorrhagic shock, many of the described treatments may be used in other situations of hypoxia or ischemia/reperfusion injury.

Original language	English (US)
Pages (from-to)	14-23
Number of pages	10
Journal	Shock
Volume	50
Issue number	1
DOIs	https://doi.org/10.1097/SHK.0000000000001094
State	Published - Jul 1 2018

Bibliographical note

Funding Information:
Address reprint requests to Andrea Wolf, Division of Critical Care and Acute Care Surgery, Department of General Surgery, University of Minnesota, 420 Delaware St SE, MMC 195, Minneapolis, MN 55455. E-mail: awolf@umn.edu Part of the work described in his review was supported by USDOD ARMY, Grant W81XWH-10-2-0121. This work was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health Award Number UL1TR000114. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Publisher Copyright:
© 2018 by the Shock Society.

Keywords

Adenosine lidocaine magnesium
D-beta-hydroxybutyrate
DADLE
ghrelin
hydrogen sulfide
hypothermia
melatonin
resuscitation

Access

10.1097/SHK.0000000000001094

OpenUrl availability

Full text

Cite this

@article{910bedbe073e420f81f87c5b1fc78f79,

title = "Hibernation-Based Approaches in the Treatment of Hemorrhagic Shock",

abstract = "Hemorrhagic shock is the leading cause of preventable death after trauma. Hibernation-based treatment approaches have been of increasing interest for various biomedical applications. Owing to apparent similarities in tissue perfusion and metabolic activity between severe blood loss and the hibernating state, hibernation-based approaches have also emerged for the treatment of hemorrhagic shock. Research has shown that hibernators are protected from shock-induced injury and inflammation. Utilizing the adaptive mechanisms that prevent injury in these animals may help alleviate the detrimental effects of hemorrhagic shock in non-hibernating species. This review describes hibernation-based preclinical and clinical approaches for the treatment of severe blood loss. Treatments include the delta opioid receptor agonist D-Ala 2-Leu 5-enkephalin (DADLE), the gasotransmitter hydrogen sulfide, combinations of adenosine, lidocaine, and magnesium (ALM) or D-beta-hydroxybutyrate and melatonin (BHB/M), and therapeutic hypothermia. While we focus on hemorrhagic shock, many of the described treatments may be used in other situations of hypoxia or ischemia/reperfusion injury.",

keywords = "Adenosine lidocaine magnesium, D-beta-hydroxybutyrate, DADLE, ghrelin, hydrogen sulfide, hypothermia, melatonin, resuscitation",

author = "Andrea Wolf and Lusczek, {Elizabeth R.} and Beilman, {Gregory J.}",

note = "Funding Information: Address reprint requests to Andrea Wolf, Division of Critical Care and Acute Care Surgery, Department of General Surgery, University of Minnesota, 420 Delaware St SE, MMC 195, Minneapolis, MN 55455. E-mail: awolf@umn.edu Part of the work described in his review was supported by USDOD ARMY, Grant W81XWH-10-2-0121. This work was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health Award Number UL1TR000114. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Publisher Copyright: {\textcopyright} 2018 by the Shock Society.",

year = "2018",

month = jul,

day = "1",

doi = "10.1097/SHK.0000000000001094",

language = "English (US)",

volume = "50",

pages = "14--23",

journal = "Shock",

issn = "1073-2322",

publisher = "Lippincott Williams and Wilkins",

number = "1",

}

TY - JOUR

T1 - Hibernation-Based Approaches in the Treatment of Hemorrhagic Shock

AU - Wolf, Andrea

AU - Lusczek, Elizabeth R.

AU - Beilman, Gregory J.

N1 - Funding Information: Address reprint requests to Andrea Wolf, Division of Critical Care and Acute Care Surgery, Department of General Surgery, University of Minnesota, 420 Delaware St SE, MMC 195, Minneapolis, MN 55455. E-mail: awolf@umn.edu Part of the work described in his review was supported by USDOD ARMY, Grant W81XWH-10-2-0121. This work was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health Award Number UL1TR000114. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Publisher Copyright: © 2018 by the Shock Society.

PY - 2018/7/1

Y1 - 2018/7/1

N2 - Hemorrhagic shock is the leading cause of preventable death after trauma. Hibernation-based treatment approaches have been of increasing interest for various biomedical applications. Owing to apparent similarities in tissue perfusion and metabolic activity between severe blood loss and the hibernating state, hibernation-based approaches have also emerged for the treatment of hemorrhagic shock. Research has shown that hibernators are protected from shock-induced injury and inflammation. Utilizing the adaptive mechanisms that prevent injury in these animals may help alleviate the detrimental effects of hemorrhagic shock in non-hibernating species. This review describes hibernation-based preclinical and clinical approaches for the treatment of severe blood loss. Treatments include the delta opioid receptor agonist D-Ala 2-Leu 5-enkephalin (DADLE), the gasotransmitter hydrogen sulfide, combinations of adenosine, lidocaine, and magnesium (ALM) or D-beta-hydroxybutyrate and melatonin (BHB/M), and therapeutic hypothermia. While we focus on hemorrhagic shock, many of the described treatments may be used in other situations of hypoxia or ischemia/reperfusion injury.

AB - Hemorrhagic shock is the leading cause of preventable death after trauma. Hibernation-based treatment approaches have been of increasing interest for various biomedical applications. Owing to apparent similarities in tissue perfusion and metabolic activity between severe blood loss and the hibernating state, hibernation-based approaches have also emerged for the treatment of hemorrhagic shock. Research has shown that hibernators are protected from shock-induced injury and inflammation. Utilizing the adaptive mechanisms that prevent injury in these animals may help alleviate the detrimental effects of hemorrhagic shock in non-hibernating species. This review describes hibernation-based preclinical and clinical approaches for the treatment of severe blood loss. Treatments include the delta opioid receptor agonist D-Ala 2-Leu 5-enkephalin (DADLE), the gasotransmitter hydrogen sulfide, combinations of adenosine, lidocaine, and magnesium (ALM) or D-beta-hydroxybutyrate and melatonin (BHB/M), and therapeutic hypothermia. While we focus on hemorrhagic shock, many of the described treatments may be used in other situations of hypoxia or ischemia/reperfusion injury.

KW - Adenosine lidocaine magnesium

KW - D-beta-hydroxybutyrate

KW - DADLE

KW - ghrelin

KW - hydrogen sulfide

KW - hypothermia

KW - melatonin

KW - resuscitation

UR - http://www.scopus.com/inward/record.url?scp=85048310586&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048310586&partnerID=8YFLogxK

U2 - 10.1097/SHK.0000000000001094

DO - 10.1097/SHK.0000000000001094

M3 - Review article

C2 - 29283978

AN - SCOPUS:85048310586

SN - 1073-2322

VL - 50

SP - 14

EP - 23

JO - Shock

JF - Shock

IS - 1

ER -

Hibernation-Based Approaches in the Treatment of Hemorrhagic Shock

Abstract

Bibliographical note

Keywords

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this